skip to main content

Title: On the Value of Out-of-Distribution Testing: An Example of Goodhart's Law
Out-of-distribution (OOD) testing is increasingly popular for evaluating a machine learning system's ability to generalize beyond the biases of a training set. OOD benchmarks are designed to present a different joint distribution of data and labels between training and test time. VQA-CP has become the standard OOD benchmark for visual question answering, but we discovered three troubling practices in its current use. First, most published methods rely on explicit knowledge of the construction of the OOD splits. They often rely on ``inverting'' the distribution of labels, e.g. answering mostly 'yes' when the common training answer is 'no'. Second, the OOD test set is used for model selection. Third, a model's in-domain performance is assessed after retraining it on in-domain splits (VQA v2) that exhibit a more balanced distribution of labels. These three practices defeat the objective of evaluating generalization, and put into question the value of methods specifically designed for this dataset. We show that embarrassingly-simple methods, including one that generates answers at random, surpass the state of the art on some question types. We provide short- and long-term solutions to avoid these pitfalls and realize the benefits of OOD evaluation.
Authors:
; ; ; ; ;
Award ID(s):
1909696
Publication Date:
NSF-PAR ID:
10274717
Journal Name:
Neural Information and Processing Systems (NeurIPS)
Sponsoring Org:
National Science Foundation
More Like this
  1. While progress has been made on the visual question answering leaderboards, models often utilize spurious correlations and priors in datasets under the i.i.d. setting. As such, evaluation on out-of-distribution (OOD) test samples has emerged as a proxy for generalization. In this paper, we present \textit{MUTANT}, a training paradigm that exposes the model to perceptually similar, yet semantically distinct \textit{mutations} of the input, to improve OOD generalization, such as the VQA-CP challenge. Under this paradigm, models utilize a consistency-constrained training objective to understand the effect of semantic changes in input (question-image pair) on the output (answer). Unlike existing methods on VQA-CP, \textit{MUTANT} does not rely on the knowledge about the nature of train and test answer distributions. \textit{MUTANT} establishes a new state-of-the-art accuracy on VQA-CP with a 10.57{\%} improvement. Our work opens up avenues for the use of semantic input mutations for OOD generalization in question answering.
  2. A critical problem in deep learning is that systems learn inappropriate biases, resulting in their inability to perform well on minority groups. This has led to the creation of multiple algorithms that endeavor to mitigate bias. However, it is not clear how effective these methods are. This is because study protocols differ among papers, systems are tested on datasets that fail to test many forms of bias, and systems have access to hidden knowledge or are tuned specifically to the test set. To address this, we introduce an improved evaluation protocol, sensible metrics, and a new dataset, which enables us to ask and answer critical questions about bias mitigation algorithms. We evaluate seven state-of-the-art algorithms using the same network architecture and hyperparameter selection policy across three benchmark datasets. We introduce a new dataset called Biased MNIST that enables assessment of robustness to multiple bias sources. We use Biased MNIST and a visual question answering (VQA) benchmark to assess robustness to hidden biases. Rather than only tuning to the test set distribution, we study robustness across different tuning distributions, which is critical because for many applications the test distribution may not be known during development. We find that algorithms exploit hiddenmore »biases, are unable to scale to multiple forms of bias, and are highly sensitive to the choice of tuning set. Based on our findings, we implore the community to adopt more rigorous assessment of future bias mitigation methods. All data, code, and results are publicly available.« less
  3. null (Ed.)
    Abstract Medical images are difficult to comprehend for a person without expertise. The scarcity of medical practitioners across the globe often face the issue of physical and mental fatigue due to the high number of cases, inducing human errors during the diagnosis. In such scenarios, having an additional opinion can be helpful in boosting the confidence of the decision maker. Thus, it becomes crucial to have a reliable visual question answering (VQA) system to provide a ‘second opinion’ on medical cases. However, most of the VQA systems that work today cater to real-world problems and are not specifically tailored for handling medical images. Moreover, the VQA system for medical images needs to consider a limited amount of training data available in this domain. In this paper, we develop MedFuseNet , an attention-based multimodal deep learning model, for VQA on medical images taking the associated challenges into account. Our MedFuseNet aims at maximizing the learning with minimal complexity by breaking the problem statement into simpler tasks and predicting the answer. We tackle two types of answer prediction—categorization and generation. We conducted an extensive set of quantitative and qualitative analyses to evaluate the performance of MedFuseNet . Our experiments demonstrate that MedFuseNet outperforms themore »state-of-the-art VQA methods, and that visualization of the captured attentions showcases the intepretability of our model’s predicted results.« less
  4. Open-domain question answering answers a question based on evidence retrieved from a large corpus. State-of-the-art neural approaches require intermediate evidence annotations for training. However, such intermediate annotations are expensive, and methods that rely on them cannot transfer to the more common setting, where only question– answer pairs are available. This paper investigates whether models can learn to find evidence from a large corpus, with only distant supervision from answer labels for model training, thereby generating no additional annotation cost. We introduce a novel approach (DISTDR) that iteratively improves over a weak retriever by alternately finding evidence from the up-to-date model and encouraging the model to learn the most likely evidence. Without using any evidence labels, DISTDR is on par with fully-supervised state-of-theart methods on both multi-hop and singlehop QA benchmarks. Our analysis confirms that DISTDR finds more accurate evidence over iterations, which leads to model improvements. The code is available at https:// github.com/henryzhao5852/DistDR.
  5. Obeid, I. (Ed.)
    The Neural Engineering Data Consortium (NEDC) is developing the Temple University Digital Pathology Corpus (TUDP), an open source database of high-resolution images from scanned pathology samples [1], as part of its National Science Foundation-funded Major Research Instrumentation grant titled “MRI: High Performance Digital Pathology Using Big Data and Machine Learning” [2]. The long-term goal of this project is to release one million images. We have currently scanned over 100,000 images and are in the process of annotating breast tissue data for our first official corpus release, v1.0.0. This release contains 3,505 annotated images of breast tissue including 74 patients with cancerous diagnoses (out of a total of 296 patients). In this poster, we will present an analysis of this corpus and discuss the challenges we have faced in efficiently producing high quality annotations of breast tissue. It is well known that state of the art algorithms in machine learning require vast amounts of data. Fields such as speech recognition [3], image recognition [4] and text processing [5] are able to deliver impressive performance with complex deep learning models because they have developed large corpora to support training of extremely high-dimensional models (e.g., billions of parameters). Other fields that do notmore »have access to such data resources must rely on techniques in which existing models can be adapted to new datasets [6]. A preliminary version of this breast corpus release was tested in a pilot study using a baseline machine learning system, ResNet18 [7], that leverages several open-source Python tools. The pilot corpus was divided into three sets: train, development, and evaluation. Portions of these slides were manually annotated [1] using the nine labels in Table 1 [8] to identify five to ten examples of pathological features on each slide. Not every pathological feature is annotated, meaning excluded areas can include focuses particular to these labels that are not used for training. A summary of the number of patches within each label is given in Table 2. To maintain a balanced training set, 1,000 patches of each label were used to train the machine learning model. Throughout all sets, only annotated patches were involved in model development. The performance of this model in identifying all the patches in the evaluation set can be seen in the confusion matrix of classification accuracy in Table 3. The highest performing labels were background, 97% correct identification, and artifact, 76% correct identification. A correlation exists between labels with more than 6,000 development patches and accurate performance on the evaluation set. Additionally, these results indicated a need to further refine the annotation of invasive ductal carcinoma (“indc”), inflammation (“infl”), nonneoplastic features (“nneo”), normal (“norm”) and suspicious (“susp”). This pilot experiment motivated changes to the corpus that will be discussed in detail in this poster presentation. To increase the accuracy of the machine learning model, we modified how we addressed underperforming labels. One common source of error arose with how non-background labels were converted into patches. Large areas of background within other labels were isolated within a patch resulting in connective tissue misrepresenting a non-background label. In response, the annotation overlay margins were revised to exclude benign connective tissue in non-background labels. Corresponding patient reports and supporting immunohistochemical stains further guided annotation reviews. The microscopic diagnoses given by the primary pathologist in these reports detail the pathological findings within each tissue site, but not within each specific slide. The microscopic diagnoses informed revisions specifically targeting annotated regions classified as cancerous, ensuring that the labels “indc” and “dcis” were used only in situations where a micropathologist diagnosed it as such. Further differentiation of cancerous and precancerous labels, as well as the location of their focus on a slide, could be accomplished with supplemental immunohistochemically (IHC) stained slides. When distinguishing whether a focus is a nonneoplastic feature versus a cancerous growth, pathologists employ antigen targeting stains to the tissue in question to confirm the diagnosis. For example, a nonneoplastic feature of usual ductal hyperplasia will display diffuse staining for cytokeratin 5 (CK5) and no diffuse staining for estrogen receptor (ER), while a cancerous growth of ductal carcinoma in situ will have negative or focally positive staining for CK5 and diffuse staining for ER [9]. Many tissue samples contain cancerous and non-cancerous features with morphological overlaps that cause variability between annotators. The informative fields IHC slides provide could play an integral role in machine model pathology diagnostics. Following the revisions made on all the annotations, a second experiment was run using ResNet18. Compared to the pilot study, an increase of model prediction accuracy was seen for the labels indc, infl, nneo, norm, and null. This increase is correlated with an increase in annotated area and annotation accuracy. Model performance in identifying the suspicious label decreased by 25% due to the decrease of 57% in the total annotated area described by this label. A summary of the model performance is given in Table 4, which shows the new prediction accuracy and the absolute change in error rate compared to Table 3. The breast tissue subset we are developing includes 3,505 annotated breast pathology slides from 296 patients. The average size of a scanned SVS file is 363 MB. The annotations are stored in an XML format. A CSV version of the annotation file is also available which provides a flat, or simple, annotation that is easy for machine learning researchers to access and interface to their systems. Each patient is identified by an anonymized medical reference number. Within each patient’s directory, one or more sessions are identified, also anonymized to the first of the month in which the sample was taken. These sessions are broken into groupings of tissue taken on that date (in this case, breast tissue). A deidentified patient report stored as a flat text file is also available. Within these slides there are a total of 16,971 total annotated regions with an average of 4.84 annotations per slide. Among those annotations, 8,035 are non-cancerous (normal, background, null, and artifact,) 6,222 are carcinogenic signs (inflammation, nonneoplastic and suspicious,) and 2,714 are cancerous labels (ductal carcinoma in situ and invasive ductal carcinoma in situ.) The individual patients are split up into three sets: train, development, and evaluation. Of the 74 cancerous patients, 20 were allotted for both the development and evaluation sets, while the remain 34 were allotted for train. The remaining 222 patients were split up to preserve the overall distribution of labels within the corpus. This was done in hope of creating control sets for comparable studies. Overall, the development and evaluation sets each have 80 patients, while the training set has 136 patients. In a related component of this project, slides from the Fox Chase Cancer Center (FCCC) Biosample Repository (https://www.foxchase.org/research/facilities/genetic-research-facilities/biosample-repository -facility) are being digitized in addition to slides provided by Temple University Hospital. This data includes 18 different types of tissue including approximately 38.5% urinary tissue and 16.5% gynecological tissue. These slides and the metadata provided with them are already anonymized and include diagnoses in a spreadsheet with sample and patient ID. We plan to release over 13,000 unannotated slides from the FCCC Corpus simultaneously with v1.0.0 of TUDP. Details of this release will also be discussed in this poster. Few digitally annotated databases of pathology samples like TUDP exist due to the extensive data collection and processing required. The breast corpus subset should be released by November 2021. By December 2021 we should also release the unannotated FCCC data. We are currently annotating urinary tract data as well. We expect to release about 5,600 processed TUH slides in this subset. We have an additional 53,000 unprocessed TUH slides digitized. Corpora of this size will stimulate the development of a new generation of deep learning technology. In clinical settings where resources are limited, an assistive diagnoses model could support pathologists’ workload and even help prioritize suspected cancerous cases. ACKNOWLEDGMENTS This material is supported by the National Science Foundation under grants nos. CNS-1726188 and 1925494. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. REFERENCES [1] N. Shawki et al., “The Temple University Digital Pathology Corpus,” in Signal Processing in Medicine and Biology: Emerging Trends in Research and Applications, 1st ed., I. Obeid, I. Selesnick, and J. Picone, Eds. New York City, New York, USA: Springer, 2020, pp. 67 104. https://www.springer.com/gp/book/9783030368432. [2] J. Picone, T. Farkas, I. Obeid, and Y. Persidsky, “MRI: High Performance Digital Pathology Using Big Data and Machine Learning.” Major Research Instrumentation (MRI), Division of Computer and Network Systems, Award No. 1726188, January 1, 2018 – December 31, 2021. https://www. isip.piconepress.com/projects/nsf_dpath/. [3] A. Gulati et al., “Conformer: Convolution-augmented Transformer for Speech Recognition,” in Proceedings of the Annual Conference of the International Speech Communication Association (INTERSPEECH), 2020, pp. 5036-5040. https://doi.org/10.21437/interspeech.2020-3015. [4] C.-J. Wu et al., “Machine Learning at Facebook: Understanding Inference at the Edge,” in Proceedings of the IEEE International Symposium on High Performance Computer Architecture (HPCA), 2019, pp. 331–344. https://ieeexplore.ieee.org/document/8675201. [5] I. Caswell and B. Liang, “Recent Advances in Google Translate,” Google AI Blog: The latest from Google Research, 2020. [Online]. Available: https://ai.googleblog.com/2020/06/recent-advances-in-google-translate.html. [Accessed: 01-Aug-2021]. [6] V. Khalkhali, N. Shawki, V. Shah, M. Golmohammadi, I. Obeid, and J. Picone, “Low Latency Real-Time Seizure Detection Using Transfer Deep Learning,” in Proceedings of the IEEE Signal Processing in Medicine and Biology Symposium (SPMB), 2021, pp. 1 7. https://www.isip. piconepress.com/publications/conference_proceedings/2021/ieee_spmb/eeg_transfer_learning/. [7] J. Picone, T. Farkas, I. Obeid, and Y. Persidsky, “MRI: High Performance Digital Pathology Using Big Data and Machine Learning,” Philadelphia, Pennsylvania, USA, 2020. https://www.isip.piconepress.com/publications/reports/2020/nsf/mri_dpath/. [8] I. Hunt, S. Husain, J. Simons, I. Obeid, and J. Picone, “Recent Advances in the Temple University Digital Pathology Corpus,” in Proceedings of the IEEE Signal Processing in Medicine and Biology Symposium (SPMB), 2019, pp. 1–4. https://ieeexplore.ieee.org/document/9037859. [9] A. P. Martinez, C. Cohen, K. Z. Hanley, and X. (Bill) Li, “Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ,” Arch. Pathol. Lab. Med., vol. 140, no. 7, pp. 686–689, Apr. 2016. https://doi.org/10.5858/arpa.2015-0238-OA.« less